SEARCH

SEARCH BY CITATION

References

  • Alexander SPH, Mathie A, Peters JA (2011). Guide to Receptors and Channels (GRAC), 5th Edition. Br J Pharmacol 164 (Suppl. 1): S1S324.
  • Alhaider IA, Aleisa AM, Tran TT, Alzoubi KH, Alkadhi KA (2010). Chronic caffeine treatment prevents sleep deprivation-induced impairment of cognitive function and synaptic plasticity. Sleep 33: 437444.
  • Antoniou K, Papadopoulou-Daifoti Z, Hyphantis T, Papathanasiou G, Bekris E, Marselos M et al. (2005). A detailed behavioral analysis of the acute motor effects of caffeine in the rat: involvement of adenosine A1 and A2A receptors. Psychopharmacology 183: 154162.
  • Arendash GW, Mori T, Cao C, Mamcarz M, Runfeldt M, Dickson A et al. (2009). Caffeine reverses cognitive impairment and decreases brain amyloid-beta levels in aged Alzheimer's disease mice. J Alzheimers Dis 17: 661680.
  • Bain JN, Prendergast MA, Terry AV Jr, Arneric SP, Smith MA, Buccafusco JJ (2003). Enhanced attention in rhesus monkeys as a common factor for the cognitive effects of drugs with abuse potential. Psychopharmacology 169: 150160.
  • Buffalo EA, Gillam MP, Allen RR, Paule MG (1993). Acute effects of caffeine on several operant behaviors in rhesus monkeys. Pharmacol Biochem Behav 46: 733737.
  • Bushnell PJ (1988). Effects of delay, intertrial interval, delay behavior and trimethyltin on spatial delayed response in rats. Neurotoxicol Teratol 10: 237244.
  • Castellano C, Rossi-Arnaud C, Cestari V, Costanzi M (2003). Cannabinoids and memory: animal studies. Curr Drug Targets CNS Neurol Disord 2: 389402.
  • Chudasama Y, Muir JL (1997). A behavioural analysis of the delayed non-matching to position task: the effects of scopolamine, lesions of the fornix and of the prelimbic region on mediating behaviours by rats. Psychopharmacology 134: 7382.
  • Cunha RA, Agostinho PM (2010). Chronic caffeine consumption prevents memory disturbance in different animal models of memory decline. J Alzheimers Dis 20 (Suppl. 1): S95116.
  • Ferré S, Lluís C, Justinova Z, Quiroz C, Orru M, Navarro G et al. (2010). Adenosine-cannabinoid receptor interactions. Implications for striatal function. Br J Pharmacol 160: 443453.
  • Glade MJ (2010). Caffeine – not just a stimulant. Nutrition 26: 932938.
  • Grant DS (1998). Directed forgetting in pigeons. In: Golding JM, MacLeod C (eds). Intentional Forgetting: Interdisciplinary Approaches. Erlbaum: Hillsdale, NJ, pp. 239264.
  • Hampson RE, Deadwyler SA (2000). Cannabinoids reveal the necessity of hippocampal neural encoding for short-term memory in rats. J Neurosci 20: 89328942.
  • Hasher L, Zacks RT (1979). Automatic and effortful processes in memory. J Exp Psychol Gen 108: 356388.
  • Herremans AH, Hijzen TH, Welborn PF, Olivier B, Slangen JL (1996). Effects of infusion of cholinergic drugs into the prefrontal cortex area on delayed matching to position performance in the rat. Brain Res 711: 102111.
  • Heyser CJ, Hampson RE, Deadwyler SA (1993). Effects of delta-9-tetrahydrocannabinol on delayed match to sample performance in rats: alterations in short-term memory associated with changes in task specific firing of hippocampal cells. J Pharmacol Exp Ther 264: 294307.
  • Hoffman AF, Laaris N, Kawamura M, Masino SA, Lupica CR (2010). Control of cannabinoid CB1 receptor function on glutamate axon terminals by endogenous adenosine acting at A1 receptors. J Neurosci 30: 545555.
  • Holtzman SG, Finn IB (1988). Tolerance to behavioral effects of caffeine in rats. Pharmacol Biochem Behav 29: 411418.
  • Hudzik TJ, Wenger GR (1993). Effects of drugs of abuse and cholinergic agents on delayed matching-to-sample responding in the squirrel monkey. J Pharmacol Exp Ther 265: 120127.
  • James JE (1997). Understanding Caffeine: A Biobehavioral Analysis. Sage Publications: Thousand Oaks, CA.
  • Justinova Z, Ferré S, Segal PN, Antoniou K, Solinas M, Pappas LA et al. (2003). Involvement of adenosine A1 and A2A receptors in the adenosinergic modulation of the discriminative-stimulus effects of cocaine and methamphetamine in rats. J Pharmacol Exp Ther 307: 977986.
  • Karcz-Kubicha M, Antoniou K, Terasmaa A, Quarta D, Solinas M, Justinova Z et al. (2003). Involvement of adenosine A1 and A2A receptors in the motor effects of caffeine after its acute and chronic administration. Neuropsychopharmacology 28: 12811291.
  • Lane SD, Cherek DR, Lieving LM, Tcheremissine OV (2005). Marijuana effects on human forgetting functions. J Exp Anal Behav 83: 6783.
  • Lau CE, Falk JL (1995). Dose-dependent surmountability of locomotor activity in caffeine tolerance. Pharmacol Biochem Behav 52: 139143.
  • Leggett T (2006). A review of the world cannabis situation. Bull Narc 58: 1155.
  • Lichtman AH, Varvel SA, Martin BR (2002). Endocannabinoids in cognition and dependence. Prostaglandins Leukot Essent Fatty Acids 66: 269285.
  • Mallet PE, Beninger RJ (1998). The cannabinoid CB1 receptor antagonist SR141716A attenuates the memory impairment produced by delta9-tetrahydrocannabinol or anandamide. Psychopharmacology 140: 1119.
  • Monopoli A, Casati C, Lozza G, Forlani A, Ongini E (1998). Cardiovascular pharmacology of the A2A adenosine receptor antagonist, SCH 58261, in the rat. J Pharmacol Exp Ther 285: 915.
  • National Research Council (1996). Guidelines for the Care and Use of Mammals in Neuroscience and Behavioral Research. The National Academies Press: Washington, DC.
  • Nehlig A (2010). Is caffeine a cognitive enhancer? J Alzheimers Dis 20 (Suppl. 1): S85S94.
  • Orru M, Bakešová J, Brugarolas M, Quiroz C, Beaumont V, Goldberg SR et al. (2011). Striatal pre- and postsynaptic profile of adenosine A(2A) receptor antagonists. PLoS ONE 6: e16088.
  • Panlilio LV, Yasar S, Thorndike EB, Goldberg SR, Schindler CW (2011). Automatic recording of mediating behavior in delayed matching- and nonmatching-to-position procedures in rats. Psychopharmacology 214: 495504.
  • Pires VA, Pamplona FA, Pandolfo P, Fernandes D, Prediger RD, Takahashi RN (2009). Adenosine receptor antagonists improve short-term object-recognition ability of spontaneously hypertensive rats: a rodent model of attention-deficit hyperactivity disorder. Behav Pharmacol 20: 134145.
  • Pontecorvo MJ, Sahgal A, Steckler T (1996). Further developments in the measurement of working memory in rodents. Brain Res Cogn Brain Res 3: 205213.
  • Ranganathan M, D'Souza DC (2006). The acute effects of cannabinoids on memory in humans: a review. Psychopharmacology 188: 425444.
  • Reissig CJ, Strain EC, Griffiths RR (2009). Caffeinated energy drinks – a growing problem. Drug Alcohol Depend 99: 110.
  • Smith A (2002). Effects of caffeine on human behavior. Food Chem Toxicol 40: 12431255.
  • Solinas M, Goldberg SR (2005). Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats. Psychopharmacology 179: 804812.
  • Solinas M, Ferré S, Antoniou K, Quarta D, Justinova Z, Hockemeyer J et al. (2005). Involvement of adenosine A1 receptors in the discriminative-stimulus effects of caffeine in rats. Psychopharmacology 179: 576586.
  • Sousa VC, Assaife-Lopes N, Ribeiro JA, Pratt JA, Brett RR, Sebastião AM (2011). Regulation of hippocampal cannabinoid CB(1) receptor actions by adenosine A(1) receptors and chronic caffeine administration: implications for the effects of δ(9)-tetrahydrocannabinol on spatial memory. Neuropsychopharmacology 36: 472487.